Journal ArticleDOI
Cardiovascular Comorbidity in COPD: Systematic Literature Review
TLDR
Available observational data support the hypothesis that COPD is associated with an increased risk of CVD, and two studies found a relationship between the severity of airflow limitation and CVD risk.About:
This article is published in Chest.The article was published on 2013-10-01. It has received 251 citations till now. The article focuses on the topics: Rate ratio & COPD.read more
Citations
More filters
Journal ArticleDOI
The evaluation of cardiac functions according to chronic obstructive pulmonary disease groups.
TL;DR: The results suggest that patients’ symptoms in symptomatic COPD groups B and D might be related to increased PAP and concomitant cardiovascular comorbidities, and a detailed cardiovascular investigation should be performed from early stages in COPD.
Journal ArticleDOI
Use of CHA 2 DS 2 -VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study -
Wei-Syun Hu,Cheng-Li Lin +1 more
TL;DR: Risk of new-onset AF in COPD patients increased with increasing CHA2DS2-VASc score, and the predictive ability of the score was moderate, which might be used as a screening tool for AF in patients with chronic obstructive pulmonary disease.
Posted ContentDOI
Influence of blood pressure on pneumonia risk: Epidemiological association and Mendelian randomisation in the UK Biobank
Seyedeh M. Zekavat,Michael C. Honigberg,James P. Pirruccello,Puja Kohli,Elizabeth W. Karlson,Elizabeth W. Karlson,Christopher Newton-Cheh,Hongyu Zhao,Pradeep Natarajan +8 more
TL;DR: It is strongly suggested that elevated blood pressure independently increases risk for pneumonia and reduces pulmonary function, and maintaining adequate blood pressure control, in addition to other measures, may reduce risk of pneumonia.
Journal ArticleDOI
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis
Hana Müllerová,Jonathan Marshall,E De Nigris,Precil Varghese,N Pooley,Nina Embleton,Clementine Nordon,Zoe R. Marjenberg +7 more
TL;DR: Although the underlying mechanisms are not fully elucidated, patients with COPD should be monitored for risk of CV outcomes after exacerbations and preventing exacerbations may decrease the risk of subsequent acute CV events.
Journal ArticleDOI
Experimental dyspnea interferes with locomotion and cognition: a randomised trial
David Lawi,Elise-Lozeron Dupuis,Elise-Lozeron Dupuis,Gregory Berra,Gilles Allali,Gilles Allali,Gilles Allali,Thomas Similowski,Dan Adler,Dan Adler +9 more
TL;DR: The data suggest that respiratory threshold loading to elicit dyspnoea had a major impact on locomotion and cognitive function in healthy adults and there is a need for clinical interventions to improve non-respiratory symptoms of chronic respiratory diseases by focussing on alleviating dysPNoea.
References
More filters
Journal ArticleDOI
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo,Suzanne S. Hurd,Alvar Agusti,Paul W. Jones,Claus Vogelmeier,Antonio Anzueto,Peter J. Barnes,Leonardo M. Fabbri,Fernando J. Martinez,Masaharu Nishimura,Robert A. Stockley,Don D. Sin,Roberto Rodriguez-Roisin +12 more
TL;DR: It is recommended that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation.
Journal ArticleDOI
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
TL;DR: Reduced lung function is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD.
Journal ArticleDOI
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.
TL;DR: Subjects with GOLD stage 3 or 4 COPD had a higher prevalence of diabetes, which contributes to a higher risk of adverse outcomes of mortality and hospitalisations, and subjects with impaired lung function had more comorbid disease.
Journal ArticleDOI
Mortality in COPD: Role of comorbidities.
TL;DR: The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructives pulmonary disease and comorbrid conditions (i.e. inflammation), and the tools used to predict Chronic obstructivemonary disease mortality.
Journal ArticleDOI
Systemic effects of chronic obstructive pulmonary disease
TL;DR: In this article, the authors discuss the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; 4) other potential systemic effects.